MarketInOut Stock Screener Log In | Sign Up

Assembly Biosciences Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 10/30/2026
Assembly Biosciences Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization409.86 mln
Float12.80 mln
Earnings Date11/11/2026

EPS

1.04
Moderate

P / E

19.36
Moderately valued

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

2.31
Highly suspicious

Relative Strength

58 / 100
Slightly ahead

Debt / Equity

0.01
Debt-free

Business Description

Assembly Biosciences is a South San Francisco-based biotechnology company focused on developing new treatments for viral infections, including herpes, hepatitis B, and hepatitis delta virus. The company has several drug candidates at various stages of clinical testing, spanning both injectable and oral treatment options. It works alongside Gilead Sciences under a research and licensing agreement to advance antiviral therapies.

Key Fundamentals

EPS1.04
P/E19.36
ROE-0.02
RPS4.57
ROIC-21.41
ROA-0.02
EBITDA, mln0.07
EV / EBITDA999
EV / EBIT-1,617
Revenue, mln74.85
EV / Revenue0.91

Quote Details

Last 20.13
Change -0.73 (-3.5%)
Open 20.86
Volume 136,867
Turnover 2,755,132
Average Volume 216,364

Financial Ratios

Pre-Tax Profit Margin-0
Leverage Ratio1.08
Current Ratio13.99
Price / Book1.32
Price / Tangible Book1.32
Debt / Equity0.01
Price / Sales4.31

Financial Strength

Altman Z-Score7.3
Piotroski F-Score 5 / 9
Beneish M-Score2.31
Short Ratio8.29
Short % of Float19.05

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 1.46% 77 / 100   
1 Month -12.4% 26 / 100   
2 Months -22.31% 21 / 100   
6 Months -26.45% 23 / 100   
1 Year -35.04% 24 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog